Quick Answer
NEPHROS INC reported Research And Development Expense of $1.34 million for the year ending 2025.
- NEPHROS INC showed an increase of +47.8% in Research And Development Expense from 2024 to 2025.
- This data is from NEPHROS INC's annual report (Form 10-K), filed with the SEC on March 12, 2026.
- XBRL data for this metric is available from 2018 to 2025 (8 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 8 years of available data (2018 to 2025), NEPHROS INC's Research And Development Expense has declined by 13.0%.
- Historical annual values: Fiscal year 2025: $1.34 million | Fiscal year 2024: $906.0 thousand | Fiscal year 2023: $873.0 thousand | Fiscal year 2022: $1.26 million | Fiscal year 2021: $1.50 million | Fiscal year 2020: $2.76 million | Fiscal year 2019: $3.09 million | Fiscal year 2018: $1.54 million.
- Data sourced from SEC EDGAR public filings as of June 20, 2026.
Last verified: